Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wiedermann

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Antimicrobial Agents and Chemotherapy|April 17, 2001
Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolyticaK Seifert, M Duchêne, W H Wernsdorfer, et al.
Vaccine|January 1, 1992
Simultaneous vaccination against hepatitis A and B: results of a controlled studyF Ambrosch, F E André, A Delem, et al.
Archives of Medical Research|January 1, 1992
Molecular characterization of IgG and IgE antigens of Entamoeba histolyticaB Plaimauer, S Ortner, M Födinger, et al.
Parasitology Research|June 14, 2001
Recombinant dissection of myosin heavy chain of Toxocara canis shows strong clustering of antigenic regionsA Obwaller, M Duchêne, H Bruhn, et al.
Vaccine|March 15, 2000
A hepatitis B vaccine formulated with a novel adjuvant systemF Ambrosch, G Wiedermann, M Kundi, et al.
Archives of Medical Research|November 9, 2000
Isolation of phage mimotopes mimicking a protective epitope of GPI-linked proteophosphoglycan antigens of Entamoeba histolyticaH Melzer, F Felici, E Mansouri, et al.
The Journal of Infectious Diseases|January 7, 1999
Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccinesT F Tsai, H Kollaritsch, J U Que, et al.
Bulletin of the World Health Organization|January 1, 1989
In vitro drug sensitivity of Plasmodium falciparum in Acre, BrazilP G Kremsner, G M Zotter, H Feldmeier, et al.
Journal of Medical Virology|December 1, 1994
Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccineF Ambrosch, G Wiedermann, F E André, et al.
Vaccine|September 1, 1987
Multicentre dose range study of a yeast-derived hepatitis B vaccineG Wiedermann, N Scheiermann, P Goubau, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|April 17, 2001
Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolyticaK Seifert, M Duchêne, W H Wernsdorfer, et al.
Vaccine|January 1, 1992
Simultaneous vaccination against hepatitis A and B: results of a controlled studyF Ambrosch, F E André, A Delem, et al.
Archives of Medical Research|January 1, 1992
Molecular characterization of IgG and IgE antigens of Entamoeba histolyticaB Plaimauer, S Ortner, M Födinger, et al.
Parasitology Research|June 14, 2001
Recombinant dissection of myosin heavy chain of Toxocara canis shows strong clustering of antigenic regionsA Obwaller, M Duchêne, H Bruhn, et al.
Vaccine|March 15, 2000
A hepatitis B vaccine formulated with a novel adjuvant systemF Ambrosch, G Wiedermann, M Kundi, et al.
Archives of Medical Research|November 9, 2000
Isolation of phage mimotopes mimicking a protective epitope of GPI-linked proteophosphoglycan antigens of Entamoeba histolyticaH Melzer, F Felici, E Mansouri, et al.
The Journal of Infectious Diseases|January 7, 1999
Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccinesT F Tsai, H Kollaritsch, J U Que, et al.
Bulletin of the World Health Organization|January 1, 1989
In vitro drug sensitivity of Plasmodium falciparum in Acre, BrazilP G Kremsner, G M Zotter, H Feldmeier, et al.
Journal of Medical Virology|December 1, 1994
Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccineF Ambrosch, G Wiedermann, F E André, et al.
Vaccine|September 1, 1987
Multicentre dose range study of a yeast-derived hepatitis B vaccineG Wiedermann, N Scheiermann, P Goubau, et al.
Pageof 17